Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Rheumatology International
|
November 12, 2018
Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
Klaus Krüger, Gerd R Burmester, Siegfried Wassenberg, et al.
BMJ Open
|
June 16, 2018
Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
Klaus Krüger, Gerd R Burmester, Siegfried Wassenberg, et al.
Arthritis and Rheumatism
|
March 4, 2008
Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Joachim Listing, Anja Strangfeld, Jörn Kekow, et al.
Clinical and Experimental Rheumatology
|
December 16, 2016
Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline
Carolin Krause, Gertraud Herborn, Juergen Braun, et al.
Clinical Rheumatology
|
January 30, 2015
Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice
Marina Backhaus, Jörg Kaufmann, Constanze Richter, et al.
Arthritis Care & Research
|
September 30, 2021
Association Between Rheumatoid Arthritis Disease Activity and Periodontitis Defined by Tooth Loss: Longitudinal and Cross-Sectional Data From Two Observational Studies
Katinka Albrecht, Paola de Pablo, Thorsten Eidner, et al.
The Journal of Rheumatology
|
March 17, 2019
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis
Jürgen Braun, Xenofon Baraliakos, Uta Kiltz, et al.
Rheumatology and Therapy
|
September 20, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy
|
October 17, 2022
Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy
|
November 29, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Rheumatology International
|
November 12, 2018
Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
Klaus Krüger, Gerd R Burmester, Siegfried Wassenberg, et al.
BMJ Open
|
June 16, 2018
Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
Klaus Krüger, Gerd R Burmester, Siegfried Wassenberg, et al.
Arthritis and Rheumatism
|
March 4, 2008
Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Joachim Listing, Anja Strangfeld, Jörn Kekow, et al.
Clinical and Experimental Rheumatology
|
December 16, 2016
Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline
Carolin Krause, Gertraud Herborn, Juergen Braun, et al.
Clinical Rheumatology
|
January 30, 2015
Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice
Marina Backhaus, Jörg Kaufmann, Constanze Richter, et al.
Arthritis Care & Research
|
September 30, 2021
Association Between Rheumatoid Arthritis Disease Activity and Periodontitis Defined by Tooth Loss: Longitudinal and Cross-Sectional Data From Two Observational Studies
Katinka Albrecht, Paola de Pablo, Thorsten Eidner, et al.
The Journal of Rheumatology
|
March 17, 2019
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis
Jürgen Braun, Xenofon Baraliakos, Uta Kiltz, et al.
Rheumatology and Therapy
|
September 20, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy
|
October 17, 2022
Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy
|
November 29, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Page
of 5